|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
At the present time there are no contraindications for the use of This medicine when used as recommended.
A transient rise of intraocular pressure postoperatively has been reported in some cases. In posterior segment surgery intraocular pressure rises have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of Healon. Rarely, postoperative inflammatory reactions liritis, hypopyon as well as incidents of corneal edema and corneal decompensation have been reported.
No information provided.
Those precautions normally considered during anterior segment and retinal attachment procedures are recommended. Transient increases in intraocular pressure may occur following surgery because of preexisting glaucoma or due to the surgery itself. For these reasons, the following precautions should be considered: • An excess quantity of This medicine should not be used. • This medicine should be thoroughly removed from the anterior chamber after surgery to prevent or minimize post-operative intraocular pressure increases (spikes). • If the post-operative intraocular pressure increases above expected values, appropriate therapy should be initiated. • This medicine is prepared from a biological source and the physician should be aware of the possible effects of using any biological material. • A single use disposable cannula, such as the one provided in this package, should be used when administering This medicine. Reuse of cannula should be avoided. The repeated use of a cannula could release particulate matter as This medicine is injected. • There have been isolated reports of diffuse particulates or haziness appearing after injection of products similar to this medicine into the eye. While such reports are infrequent and seldom associated with any effects on ocular tissues, the physician should be aware of the occurrence. If observed, the particulate matter should be removed by irrigation and or aspiration.
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Tahsin Martini
Yaser Habrawi , F.R.C.S.Ed
Samir Moussa M.D.
Dr. Samer Al-Jneidy
Dr . Dirar Abboud
Dr. Hani Najjar
Dr. Talal Sabouni
Dr. Faisal Dibsi